The American Association of Retired Persons, Washington, will join the Prescription Access Litigation Project, Boston, in three federal class-action lawsuits against pharmaceutical companies that the two groups argue are preventing consumers from getting generic versions of drugs. The suits mark the first time that the AARP, representing 35 million elderly, has engaged in antitrust litigation against drug manufacturers. The cases involve alleged patent abuse by Bristol-Myers Squibb Co., relating to its anti-anxiety drug Buspirone; alleged anticompetitive practices by AstraZeneca, relating to the breast-cancer treatment tamoxifen; and alleged anticompetitive activity by three pharmaceutical companies relating to blood pressure medicines.
AARP signs on to suits against drug manufacturers
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.